ATE284676T1 - Herstellung von wirkstoffpartikeln durch evaporation-präzipitation in wässrige lösungen - Google Patents
Herstellung von wirkstoffpartikeln durch evaporation-präzipitation in wässrige lösungenInfo
- Publication number
- ATE284676T1 ATE284676T1 AT01989339T AT01989339T ATE284676T1 AT E284676 T1 ATE284676 T1 AT E284676T1 AT 01989339 T AT01989339 T AT 01989339T AT 01989339 T AT01989339 T AT 01989339T AT E284676 T1 ATE284676 T1 AT E284676T1
- Authority
- AT
- Austria
- Prior art keywords
- drug
- precipitation
- evaporation
- production
- aqueous solutions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
Landscapes
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nanotechnology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Epidemiology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Compounds Of Unknown Constitution (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US24547900P | 2000-11-03 | 2000-11-03 | |
| US09/808,332 US6756062B2 (en) | 2000-11-03 | 2001-03-14 | Preparation of drug particles using evaporation precipitation into aqueous solutions |
| PCT/US2001/051337 WO2002047659A2 (en) | 2000-11-03 | 2001-10-22 | Preparation of drug particles using evaporation precipitation into aqueous solutions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE284676T1 true ATE284676T1 (de) | 2005-01-15 |
Family
ID=26937266
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01989339T ATE284676T1 (de) | 2000-11-03 | 2001-10-22 | Herstellung von wirkstoffpartikeln durch evaporation-präzipitation in wässrige lösungen |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US6756062B2 (de) |
| EP (1) | EP1335705B1 (de) |
| JP (1) | JP2004515525A (de) |
| AT (1) | ATE284676T1 (de) |
| AU (1) | AU2002243441A1 (de) |
| CA (1) | CA2427625A1 (de) |
| DE (1) | DE60107872T2 (de) |
| WO (1) | WO2002047659A2 (de) |
Families Citing this family (54)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7425543B2 (en) * | 1992-11-16 | 2008-09-16 | The Corporation Of Mercer University | Microencapsulated materials and method of making same |
| US9006175B2 (en) | 1999-06-29 | 2015-04-14 | Mannkind Corporation | Potentiation of glucose elimination |
| US8551526B2 (en) * | 2000-11-03 | 2013-10-08 | Board Of Regents, The University Of Texas System | Preparation of drug particles using evaporation precipitation into aqueous solutions |
| EP1345968A2 (de) * | 2000-12-28 | 2003-09-24 | Altus Biologics Inc. | Kristalle ganzer antikörper und fragmente davon und verfahren zu ihrer herstellung und verwendung |
| JP2005500304A (ja) * | 2001-06-21 | 2005-01-06 | アルタス バイオロジックス インコーポレイテッド | 球状タンパク質粒子およびそれらの作製方法および使用方法 |
| WO2003000226A2 (en) * | 2001-06-22 | 2003-01-03 | Pfizer Products Inc. | Pharmaceutical compositions containing polymer and drug assemblies |
| WO2003032951A1 (en) * | 2001-08-29 | 2003-04-24 | Dow Global Technologies Inc. | A process for preparing crystalline drug particles by means of precipitation |
| JP4681231B2 (ja) | 2002-03-20 | 2011-05-11 | マンカインド コーポレイション | 吸入装置 |
| CA2526454C (en) | 2003-05-22 | 2013-08-13 | Applied Nanosystems B.V. | Gel-assisted production of small particles |
| US20050175683A1 (en) * | 2003-10-24 | 2005-08-11 | Yuanpeng Zhang | Preparation of lipid particles |
| US7754243B2 (en) * | 2004-08-03 | 2010-07-13 | Clemson University Research Foundation | Aqueous suspension of nanoscale drug particles from supercritical fluid processing |
| ATE486064T1 (de) | 2004-08-20 | 2010-11-15 | Mannkind Corp | Katalyse der diketopiperazinsynthese |
| HUE025151T2 (en) | 2004-08-23 | 2016-01-28 | Mannkind Corp | Diceto-piperazine salts for drug delivery |
| EP1789018A1 (de) * | 2004-08-27 | 2007-05-30 | The Dow Chemical Company | Verbesserte abgabe von medikamentenzusammensetzungen zur behandlung lebensbedrohender infektionen |
| MX2007013356A (es) * | 2005-04-27 | 2008-03-26 | Baxter Int | Microparticulas modificadas en la superficie y metodos de formacion y uso de las mismas. |
| MX373000B (es) * | 2005-09-14 | 2020-05-21 | Mannkind Corp | Metodo para formulacion de farmaco basado en el aumento de la afinidad de agentes activos hacia las superficies de microparticulas cristalinas. |
| CN104383546B (zh) | 2006-02-22 | 2021-03-02 | 曼金德公司 | 用于改善包含二酮哌嗪和活性剂的微粒的药物性质的方法 |
| GB0613925D0 (en) * | 2006-07-13 | 2006-08-23 | Unilever Plc | Improvements relating to nanodispersions |
| MX2009003661A (es) * | 2006-10-06 | 2009-04-22 | Baxter Int | Microcapsulas que contienen microparticulas modificadas en la superficie y metodos para formar y utilizar las mismas. |
| WO2008065502A1 (en) * | 2006-11-29 | 2008-06-05 | Pfizer Products Inc. | Pharmaceutical compositions based on a) nanoparticles comprising enteric polymers and b) casein |
| US20100119612A1 (en) * | 2007-04-17 | 2010-05-13 | Bend Research, Inc | Nanoparticles comprising non-crystalline drug |
| CN101292958B (zh) * | 2007-04-27 | 2011-04-27 | 北京化工大学 | 一种超细达那唑粉体的制备方法 |
| WO2008135828A2 (en) * | 2007-05-03 | 2008-11-13 | Pfizer Products Inc. | Nanoparticles comprising a drug, ethylcellulose, and a bile salt |
| US8703204B2 (en) * | 2007-05-03 | 2014-04-22 | Bend Research, Inc. | Nanoparticles comprising a cholesteryl ester transfer protein inhibitor and anon-ionizable polymer |
| US20100080852A1 (en) * | 2007-05-03 | 2010-04-01 | Ronald Arthur Beyerinck | Phamaceutical composition comprising nanoparticles and casein |
| EP2162120B1 (de) * | 2007-06-04 | 2016-05-04 | Bend Research, Inc | Nanopartikel mit nicht ionisierbarem zellulosepolymer und amphipilem nicht ionisierbarem blockcopolymer |
| WO2008149230A2 (en) | 2007-06-04 | 2008-12-11 | Pfizer Products Inc. | Nanoparticles comprising drug, a non-ionizable cellulosic polymer and tocopheryl polyethylene glycol succinate |
| US20100215747A1 (en) * | 2007-07-13 | 2010-08-26 | Corey Jay Bloom | Nanoparticles comprising ionizable, poorly water soluble cellulosic polymers |
| WO2009073215A1 (en) * | 2007-12-06 | 2009-06-11 | Bend Research, Inc. | Pharmaceutical compositions comprising nanoparticles and a resuspending material |
| EP2240162A4 (de) * | 2007-12-06 | 2013-10-09 | Bend Res Inc | Nanoteilchen mit einem nicht-ionisierbaren polymer und einem amin-funktionalisierten methacrylat-copolymer |
| MY155524A (en) | 2008-06-13 | 2015-10-30 | Mannkind Corp | A dry powder inhaler and system for drug delivery |
| US8485180B2 (en) | 2008-06-13 | 2013-07-16 | Mannkind Corporation | Dry powder drug delivery system |
| EP2609954B1 (de) | 2008-06-20 | 2021-12-29 | MannKind Corporation | Interaktives Gerät für die Echtzeit-Profilierung von Inhalationsversuchen |
| US20100151037A1 (en) * | 2008-08-07 | 2010-06-17 | Yivan Jiang | Method for the preparation of nanoparticles containing a poorly water-soluble pharmaceutically active compound |
| TWI494123B (zh) | 2008-08-11 | 2015-08-01 | Mannkind Corp | 超快起作用胰島素之用途 |
| US8314106B2 (en) | 2008-12-29 | 2012-11-20 | Mannkind Corporation | Substituted diketopiperazine analogs for use as drug delivery agents |
| US8538707B2 (en) | 2009-03-11 | 2013-09-17 | Mannkind Corporation | Apparatus, system and method for measuring resistance of an inhaler |
| AU2010259943C1 (en) | 2009-06-12 | 2016-03-03 | Mannkind Corporation | Diketopiperazine microparticles with defined specific surface areas |
| JP5784622B2 (ja) | 2009-11-03 | 2015-09-24 | マンカインド コーポレ−ション | 吸入活動をシミュレートするための装置及び方法 |
| BR112012022916B1 (pt) | 2010-03-12 | 2021-11-09 | Berg Llc | Formulações intravenosas de coenzima q10 (coq10), bem como método de preparação e uso da mesma |
| RU2531455C2 (ru) | 2010-06-21 | 2014-10-20 | Маннкайнд Корпорейшн | Системы и способы доставки сухих порошковых лекарств |
| EP2608772A2 (de) * | 2010-08-23 | 2013-07-03 | President and Fellows of Harvard College | Partikel für wirkstofffreisetzung und andere anwendung |
| MX353285B (es) | 2011-04-01 | 2018-01-05 | Mannkind Corp | Paquete de blister para cartuchos farmaceuticos. |
| US20140239525A1 (en) | 2011-06-17 | 2014-08-28 | Board Of Regents, University Of Texas System | Inhalable pharmaceutical compositions |
| WO2012174472A1 (en) | 2011-06-17 | 2012-12-20 | Mannkind Corporation | High capacity diketopiperazine microparticles |
| WO2012178082A1 (en) * | 2011-06-24 | 2012-12-27 | The Trustees Of Columbia University In The City Of New York | Improved methods, devices and systems to process x-ray diffraction data |
| HK1201475A1 (en) | 2011-10-24 | 2015-09-04 | Mannkind Corporation | Methods and compositions for treating pain |
| WO2014066856A1 (en) | 2012-10-26 | 2014-05-01 | Mannkind Corporation | Inhalable influenza vaccine compositions and methods |
| BR112015023168B1 (pt) | 2013-03-15 | 2021-08-10 | Mannkind Corporation | Composição de 3,6-bis(n-fumaril-4-aminobutil)-2,5-dicetopiperazina cristalina, método de produção de partículas de 3,6-bis(n-fumaril-4-aminobutil)-2,5-dicetopiperazina e uso de uma composição de dicetopiperazina cristalina |
| BR122019026637B1 (pt) | 2013-07-18 | 2023-09-26 | Mannkind Corporation | Formulações farmacêuticas de pó seco e método para a fabricação de uma formulação de pó seco |
| CA2920488C (en) | 2013-08-05 | 2022-04-26 | Mannkind Corporation | Insufflation apparatus and methods |
| US10307464B2 (en) | 2014-03-28 | 2019-06-04 | Mannkind Corporation | Use of ultrarapid acting insulin |
| US10561806B2 (en) | 2014-10-02 | 2020-02-18 | Mannkind Corporation | Mouthpiece cover for an inhaler |
| KR102047025B1 (ko) * | 2019-05-07 | 2019-12-02 | 엔젯 주식회사 | 반도체 패키지의 언더필 방법 및 장치 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5145684A (en) | 1991-01-25 | 1992-09-08 | Sterling Drug Inc. | Surface modified drug nanoparticles |
| US5766635A (en) * | 1991-06-28 | 1998-06-16 | Rhone-Poulenc Rorer S.A. | Process for preparing nanoparticles |
| GB9313642D0 (en) | 1993-07-01 | 1993-08-18 | Glaxo Group Ltd | Method and apparatus for the formation of particles |
| GB9313650D0 (en) | 1993-07-01 | 1993-08-18 | Glaxo Group Ltd | Method and apparatus for the formation of particles |
| ES2306452T3 (es) * | 1995-10-17 | 2008-11-01 | Jagotec Ag | Aporte de farmacos insolubles. |
| US6001336A (en) | 1996-12-31 | 1999-12-14 | Inhale Therapeutic Systems | Processes for spray drying aqueous suspensions of hydrophobic drugs and compositions thereof |
-
2001
- 2001-03-14 US US09/808,332 patent/US6756062B2/en not_active Expired - Fee Related
- 2001-10-22 AU AU2002243441A patent/AU2002243441A1/en not_active Abandoned
- 2001-10-22 WO PCT/US2001/051337 patent/WO2002047659A2/en not_active Ceased
- 2001-10-22 CA CA002427625A patent/CA2427625A1/en not_active Abandoned
- 2001-10-22 DE DE60107872T patent/DE60107872T2/de not_active Expired - Lifetime
- 2001-10-22 AT AT01989339T patent/ATE284676T1/de not_active IP Right Cessation
- 2001-10-22 JP JP2002549233A patent/JP2004515525A/ja not_active Withdrawn
- 2001-10-22 EP EP01989339A patent/EP1335705B1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002047659A3 (en) | 2002-09-06 |
| AU2002243441A1 (en) | 2002-06-24 |
| WO2002047659A2 (en) | 2002-06-20 |
| DE60107872T2 (de) | 2005-05-19 |
| EP1335705A2 (de) | 2003-08-20 |
| CA2427625A1 (en) | 2002-06-20 |
| US6756062B2 (en) | 2004-06-29 |
| EP1335705B1 (de) | 2004-12-15 |
| US20020081334A1 (en) | 2002-06-27 |
| JP2004515525A (ja) | 2004-05-27 |
| DE60107872D1 (de) | 2005-01-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60107872D1 (de) | Herstellung von wirkstoffpartikeln durch evaporation-präzipitation in wässrige lösungen | |
| KR970706799A (ko) | 소립자 형성(Small Partical Formation) | |
| ES2422757T3 (es) | Uso terapéutico de microesferas de ácido nucleico | |
| ATE249813T1 (de) | Einhüllungssverfahren | |
| EP1127570A3 (de) | Verfahren zur Herstellung von wirkstofbeladenen Polymer-Micellen Zusammensetzung | |
| CY1107059T1 (el) | Υδατικη διασπορα που περιεχει σταθερα νανοσωματιδια μιας αδιαλυτης στο νερο δραστικης ουσιας κι ενα εκδοχο οπως τα τριγλυκεριδια μεσης αλυσιδας (mct) | |
| ATE294828T1 (de) | Neue polythiophen-dispersionen | |
| BR0116377A (pt) | Métodos para preparar partìculas submicronicamente dimensionadas de um composto orgânico, e para preparar uma suspensão de um composto farmaceuticamente ativo, e, composição de matéria | |
| ATE235240T1 (de) | Wässriges verfahren zur herstellung fester paroxetin-dispersionen | |
| EP1541637A4 (de) | Neues verfahren zur herstellung von pigmentnanopartikulat | |
| CA2205046A1 (en) | Pharmaceutical nanosuspensions for medicament administration as systems with increased saturation solubility and speed of dissolution | |
| ATE336231T1 (de) | Verfahren zur herstellung kristalliner arzneimittelteilchen durch ausfällung | |
| EA200000154A1 (ru) | Способ солюбилизации фармацевтически активных ингредиентов в воде и в водных носителях | |
| CN102870777A (zh) | 一种缓释抑藻剂及其制备方法 | |
| WO2006072943A3 (en) | Nano- and mesosized particles comprising an inorganic core, process and applications thereof | |
| CA2084452A1 (en) | Modified xanthan gum and method for modifying xanthan gum | |
| AU2002233822A1 (en) | Oral itraconazole formulations and methods of making the same | |
| RU99100149A (ru) | Способ получения водорастворимых производных фуллеренов | |
| Wang et al. | Recent Progress of Fuel‐Driven Temporary Materials | |
| ATE416757T1 (de) | Herstellung von mikropartikeln | |
| TW200519974A (en) | Dielectric-forming composition containing particles with perovskite crystal structure, production process and uses of the same, and process for preparing crystal particles having perovskite crystal structure | |
| JP2002518348A5 (de) | ||
| WO2005015160A3 (en) | Functionalized polymeric colloids | |
| EP1240896A3 (de) | Einkapseln von wasserlöslischen Peptiden | |
| UA29540C2 (uk) | Спосіб одержання молекулярно-колоїдних розчинів фуллеренів у воді |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |